Therapeutic effects of add-on botulinum toxin A on patients with large benign prostatic hyperplasia and unsatisfactory response to combined medical therapy

Author： Kuo Hann-Chorng   Liu Hsin-Tzu  

Publisher： Informa Healthcare

ISSN： 0036-5599

Source： Scandinavian Journal of Urology and Nephrology, Vol.43, Iss.3, 2009-04, pp. : 206-211

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Transition zone volume and transition zone ratio: predictor of uroflow response to finasteride therapy in benign prostatic hyperplasia patients

By Tewari A.   Shinohara K.   Narayan P.  

Urology, Vol. 45, Iss. 2, 1995-02 ,pp. : 258-265

Elsevier

Access to resources Recommend Favorite

Medical therapy for asymptomatic men with benign prostatic hyperplasia: primum non nocere

By Kaplan S.A.  

Urology, Vol. 62, Iss. 5, 2003-11 ,pp. : 784-785

Elsevier

Access to resources Recommend Favorite

Medical management of benign prostatic hyperplasia

By Chacon A.   Monga M.  

Geriatric Nephrology and Urology, Vol. 9, Iss. 1, 1999-01 ,pp. : 39-48

Springer Publishing Company

Access to resources Recommend Favorite

Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized, placebo-controlled study

By Maria G.   Brisinda G.   Civello I.M.   Bentivoglio A.R.   Sganga G.   Albanese A.  

Urology, Vol. 62, Iss. 2, 2003-08 ,pp. : 259-264

Elsevier

Access to resources Recommend Favorite

Intraprostatic botulinum toxin type A injection for the treatment of benign prostatic hyperplasia: Initial experience with Dysport™™

By Nikoobakht Mohammadreza   Daneshpajooh Azar   Ahmadi Hamed   Namdari Farshad   Rezaeidanesh Maedeh   Amini Shahab   Pourmand Gholamreza  

Scandinavian Journal of Urology and Nephrology, Vol. 44, Iss. 3, 2010-04 ,pp. : 151-157

Informa Healthcare

Access to resources Recommend Favorite